THE USE OF EXOGENOUS GANGLIOSIDES IN TUMORAL DISEASES AS A PROTECTIVE FACTOR AGAINST TOXICITY BY ANTITUMORAL DRUGS

摘要

The invention relates to the use of a mixture of gangliosides GM1, GD1a, GD1b and GT1b for the manufacture of a pharmaceutical composition for the prevention or the prophylactic treatment of general toxic effects or chronic neurotoxic effects caused by the subsequent administration of antineoplastic agents.